Norepinephrine as Early Vasopressor Therapy in Children Undergoing Mechanical Ventilation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00894621|
Recruitment Status : Unknown
Verified May 2009 by Unidade de Terapia Intensiva.
Recruitment status was: Active, not recruiting
First Posted : May 7, 2009
Last Update Posted : May 7, 2009
|Condition or disease||Intervention/treatment||Phase|
|Shock Mechanical Ventilation||Drug: Norepinephrine Drug: Placebo||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Norepinephrine as Early Vasopressor Therapy in Children Undergoing Mechanical Ventilation|
|Study Start Date :||November 2008|
Solution administration contend titrated norepinephrine in doses of 0,1 to 0,4 mc/kg/min. Initiated solution 24 hours after beginning mechanical ventilation. Use of the solution during 72 hours.
|Placebo Comparator: Placebo||
- To compare norepinephrine and placebo as initial therapy in pediatric patients submitted to the mechanical ventilation with reference to hemodynamic parameters, diuresis and diuretics' use. [ Time Frame: 5 days ]
- To assess possible side effects related with the early norepinephrine infusion. [ Time Frame: 5 days ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00894621
|Caxias do Sul, Rio Grande do Sul, Brazil, 95180000|